Brain Monitoring Market By Product [EEG/Magnetoencephalography (MEG)/Intracranial Pressure Monitor/Cerebral Oximeter/Transcranial Doppler] & Application [Sleep Disorders/Epilepsy/Traumatic Brain Injury/Brain Death] - Global Forecasts To 2017

The global brain monitoring devices market was valued at $1.08 billion in 2012, and is poised to grow at a CAGR of 8.6% to reach $1.63 billion by 2017. The market offers a variety of brain monitoring devices (electroencephalograph, intracranial pressure monitors, Transcranial Doppler, magnetoencephalography, and cerebral oximeters ), which help in monitoring a range of functions, such as electrical and neural activity, pressure surrounding the brain, velocity of blood flow in veins and arteries in the brain in case of epilepsy, brain death, traumatic brain injury, etc.

The brain monitoring devices market is witnessing various technological advancements leading to high functionality, lower costs, ease of operation, and miniaturization of devices fuelling the growth of this market. The traditional use of EEG devices as a diagnostic tool has now expanded to a range of applications, such as the monitoring of fatigue and stress, as a means of communication for patients with ‘locked-in syndrome’ using a brain-computer interface (BCI). Further, with the increase in computing power, more sophisticated applications of these devices are expected to develop in the future.

Rising incidences of neurological disorders, autoimmune and cardiovascular diseases, brain disorders, and sleep disorders, rising awareness regarding neurodegenerative diseases and technological advancements in brain monitoring devices are major drivers slated to propel this market. However, the shortage of skilled technicians to handle these complex devices is a factor limiting the growth of this market.

The global brain monitoring devices market was dominated by North America in 2012, followed by Europe, Asia, and Rest of the World (RoW). North America will continue to lead in the years to come, owing to technological advancements and introduction of advanced digitalized devicessuch as wireless and mobile devices. European countries are expected to grow steadily, while the Asian region’s contribution to the global brain monitoring devices market is expected to pick pace in the next few years due to increasing awareness of neurological disorders, and development in Asian healthcare infrastructure, which has resulted in an influx of well-established players to the region.

The prominent players operating in this market include Covidien, PLC (Ireland), Compumedics, Ltd.(Australia), Natus Medical, Inc. (U.S.), Nihon Kohden Corporation (Japan), Integra Life Sciences Corporation (U.S.), CAS Medical Systems (U.S.), and Advanced Brain Monitoring Inc. (U.S.), among others.

Scope of the Report

This research report categorizes the global brain monitoring devices market into the following segments and sub-segments:

The global brain monitoring devices market, by product

• Electroencephalograph
• Transcranial Doppler
• Magnetoencephalography
• Intracranial Pressure Monitor
• Cerebral Oximeter
• Accessories

The product segments are sub-segmented by their application areas into the following types:

• Electroencephalograph
  • Epilepsy
  • Sleep Disorder
  • Coma and Brain Death
  • Brain Tumor
  • Others
• Transcranial Doppler
  • Intracranial Stenosis
  • Subarachnoid Hemorrhage
  • Emboli Detection
  • Sickle Cell Disease
  • Others
• Magnetoencephalography
  • Brain Research Studies
  • Autistic Disorders
  • Others
• Intracranial Pressure Monitors
  • Traumatic Brain Injury
  • Intracerebral Hemorrhage
  • Meningitis
  • Others
• Cerebral Oximeters
  • Cardiac/Vascular Surgery
  • Shoulder Surgery
  • Single Lung Ventilation
  • Others

The global brain monitoring devices market, by end-user

• Hospitals
• Home
• Others (laboratories, research institutes, and universities)

The global brain monitoring devices market, by geography

• North America
• Europe
• Asia
• Rest of the World (RoW)

TABLE OF CONTENTS
 
1 INTRODUCTION
  1.1 KEY TAKE-AWAYS
  1.2 REPORT DESCRIPTION
  1.3 MARKETS COVERED
  1.4 STAKEHOLDERS
  1.5 RESEARCH METHODOLOGY
      1.5.1 MARKET SIZE
      1.5.2 MARKET SHARE
      1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
      1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
      1.5.5 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
  3.1 INTRODUCTION
      3.1.1 BRAIN MONITORING
      3.1.2 IMPORTANCE OF BRAIN MONITORING
  3.2 MARKET SEGMENTATION
      3.2.1 BRAIN MONITORING DEVICES MARKET, BY PRODUCT
      3.2.2 BRAIN MONITORING DEVICES MARKET, BY APPLICATION
  3.3 MARKET DYNAMICS
      3.3.1 DRIVERS
            3.3.1.1 RISING INCIDENCE OF BRAIN DISORDERS, BRAIN INJURIES, SLEEP DISORDERS AND CEREBROVASCULAR DISEASES
            3.3.1.2 INCREASING AWARENESS OF NEURODEGENERATIVE DISEASES
            3.3.1.3 TECHNOLOGICAL ADVANCEMENTS IN BRAIN MONITORING DEVICES
      3.3.2 RESTRAINT
            3.3.2.1 SHORTAGE OF TRAINED PROFESSIONALS TO HANDLE BRAIN MONITORING DEVICES
      3.3.3 OPPORTUNITIES
            3.3.3.1 CLINICAL TRIALS FOR NEURO-COGNITIVE DISEASES IS ON THE RISE
            3.3.3.2 BRAIN MONITORING DEVICES, A STANDARD IN CRITICAL CARE SETTINGS
  3.4 MARKET SHARE ANALYSIS, BY KEY PLAYERS
      3.4.1 ELECTROENCEPHALOGRAPH
            3.4.1.1 NATUS MEDICAL, INC., A DOMINANT PLAYER IN THE EEG DEVICES MARKET (2012)
      3.4.2 TRANSCRANIAL DOPPLER
            3.4.2.1 NATUS MEDICAL, INC. AND DWL COMPUMEDICS, TOP PLAYERS IN THE TCD DEVICES MARKET (2012)
      3.4.3 MAGNETOENCEPHALOGRAPH
            3.4.3.1 ELEKTA AB AND YOKOGAWA ELECTRIC CORPORATION, KEY PLAYERS IN THE MEG DEVICES MARKET (2012)
      3.4.4 INTRACRANIAL PRESSURE MONITOR
            3.4.4.1 INTEGRA LIFE SCIENCES CORPORATION AND DEPUY SYNTHES, LEADING PLAYERS IN THE ICP DEVICES MARKET (2012)
      3.4.5 CEREBRAL OXIMETER
            3.4.5.1 COVIDIEN, PLC AND CAS MEDICAL SYSTEMS, PROMINENT PLAYERS IN THE CEREBRAL OXIMETER MARKET (2012)

4 GLOBAL BRAIN MONITORING DEVICES MARKET, BY PRODUCT
  4.1 INTRODUCTION
      4.1.1 EEG DEVICES DRIVING THE BRAIN MONITORING DEVICES MARKET GLOBALLY
  4.2 ELECTROENCEPHALOGRAPH
      4.2.1 TECHNICAL OVERVIEW
      4.2.2 MARKET ANALYSIS
            4.2.2.1 INTRODUCTION OF ADVANCED DIGITAL AND WIRELESS EEG EQUIPMENT HAS CREATED A SURGE IN THE MARKET
            4.2.2.2 ASIAN EEG DEVICE MARKET IS SLATED TO GROW AT THE HIGHEST CAGR
  4.3 TRANSCRANIAL DOPPLER
      4.3.1 TECHNICAL OVERVIEW
      4.3.2 MARKET ANALYSIS
      4.3.2.1 ASIAN TCD DEVICES MARKET SHOWS ROBUST GROWTH
  4.4 MAGNETOENCEPHALOGRAPH
      4.4.1 TECHNICAL OVERVIEW
      4.4.2 MARKET ANALYSIS
  4.5 INTRACRANIAL PRESSURE MONITORS
      4.5.1 TECHNICAL OVERVIEW
      4.5.2 MARKET ANALYSIS
            4.5.2.1 CONTINUOUS ICP MONITORING RECOMMENDATION FOR TBI PATIENTS IS SET TO DRIVE THE MARKET
            4.5.2.2 ASIA WITH HIGHEST PERCENTAGE OF GLOBAL TBI PATIENTS PRESENTS HUGE POTENTIAL FOR GROWTH
  4.6 CEREBRAL OXIMETERS
      4.6.1 TECHNICAL OVERVIEW
      4.6.2 MARKET ANALYSIS
            4.6.2.1 CEREBRAL OXIMETER MARKET IS LIKELY TO GROW WITH INCREASE IN ITS CLINICAL APPLICATIONS
  4.7 ACCESSORIES
      4.7.1 TECHNICAL OVERVIEW
      4.7.2 MARKET ANALYSIS
            4.7.2.1 BATTERIES FORM THE LARGEST PRODUCT SEGMENT IN THE BRAIN MONITORING DEVICES ACCESSORIES MARKET
      4.7.3 ELECTRODES
      4.7.4 SENSORS
      4.7.5 PASTE AND GELS
      4.7.6 CAPS
      4.7.7 CABLES
      4.7.8 BATTERIES AND POWER SUPPLIES
      4.7.9 OTHERS

5 GLOBAL BRAIN MONITORING DEVICES MARKET, BY APPLICATION
  5.1 INTRODUCTION
      5.1.1 EEG DEVICES DRIVE THE MARKET GLOBALLY OWING TO ITS WIDE APPLICATIONS
  5.2 ELECTROENCEPHALOGRAPH
      5.2.1 SLEEP DISORDERS REPRESENT THE LARGEST APPLICATION MARKET FOR EEG DEVICES
      5.2.2 EPILEPSY
            5.2.2.1 TECHNICAL OVERVIEW
            5.2.2.2 MARKET ANALYSIS
                    5.2.2.2.1 RISING PATIENT POOL OF EPILEPSY AND AGING POPULATION IN NORTH AMERICA MAKES IT THE LARGEST EEG DEVICES MARKET FOR EPILEPSY
      5.2.3 SLEEP DISORDERS
            5.2.3.1 TECHNICAL OVERVIEW
            5.2.3.2 MARKET ANALYSIS
                    5.2.3.2.1 RISING AWARENESS REGARDING SLEEP DISORDERS IS LIKELY TO PROPEL GROWTH OF THE EEG DEVICES MARKET
      5.2.4 COMA & BRAIN DEATH
            5.2.4.1 TECHNICAL OVERVIEW
            5.2.4.2 MARKET ANALYSIS
                    5.2.4.2.1 LARGE NUMBER OF BRAIN INJURY ACCIDENTS IN NORTH AMERICA TO BOLSTER THE EEG DEVICES MARKET FOR COMA AND BRAIN DEATH
      5.2.5 BRAIN TUMOR
            5.2.5.1 TECHNICAL OVERVIEW
            5.2.5.2 MARKET ANALYSIS
                    5.2.5.2.1 SHARP RISE IN THE BRAIN TUMOR RATES TO DRIVE THE EEG DEVICES MARKET IN NORTH AMERICA
      5.2.6 OTHERS
  5.3 TRANSCRANIAL DOPPLER
      5.3.1 SUBARACHNOID HEMORRHAGE REPRESENTS THE LARGEST APPLICATION MARKET
      5.3.2 INTRACRANIAL STENOSIS
            5.3.2.1 TECHNICAL OVERVIEW
            5.3.2.2 MARKET ANALYSIS
      5.3.3 SUBARACHNOID HEMORRHAGE
            5.3.3.1 TECHNICAL OVERVIEW
            5.3.3.2 MARKET ANALYSIS
      5.3.4 EMBOLI DETECTION
            5.3.4.1 TECHNICAL OVERVIEW
            5.3.4.2 MARKET ANALYSIS
      5.3.5 SICKLE CELL DISEASE
            5.3.5.1 TECHNICAL OVERVIEW
            5.3.5.2 MARKET ANALYSIS
      5.3.6 OTHERS
  5.4 MAGNETOENCEPHALOGRAPH
      5.4.1 BRAIN RESEARCH STUDIES, THE LARGEST APPLICATION AREA OF MEG DEVICES.
      5.4.2 BRAIN RESEARCH STUDIES
            5.4.2.1 TECHNICAL OVERVIEW
            5.4.2.2 MARKET ANALYSIS
      5.4.3 AUTISTIC DISORDERS
            5.4.3.1 TECHNICAL OVERVIEW
            5.4.3.2 MARKET ANALYSIS
      5.4.4 OTHERS
  5.5 INTRACRANIAL PRESSURE MONITORS
      5.5.1 TRAUMATIC BRAIN INJURY, THE LARGEST APPLICATION AREA OF ICP DEVICES
      5.5.2 TRAUMATIC BRAIN INJURY
            5.5.2.1 TECHNICAL OVERVIEW
            5.5.2.2 MARKET ANALYSIS
      5.5.3 INTRACEREBRAL HEMORRHAGE
            5.5.3.1 TECHNICAL OVERVIEW
            5.5.3.2 MARKET ANALYSIS
      5.5.4 MENINGITIS
            5.5.4.1 TECHNICAL OVERVIEW
            5.5.4.2 MARKET ANALYSIS
      5.5.5 OTHERS
  5.6 CEREBRAL OXIMETERS
      5.6.1 CEREBRAL OXIMETER DEVICES MARKET IS DRIVEN BY CARDIAC/VASCULAR SURGERIES
      5.6.2 CARDIAC/ VASCULAR SURGERY
            5.6.2.1 TECHNICAL OVERVIEW
            5.6.2.2 MARKET ANALYSIS
      5.6.3 SHOULDER SURGERY
            5.6.3.1 TECHNICAL OVERVIEW
            5.6.3.2 MARKET ANALYSIS
      5.6.4 SINGLE LUNG VENTILATION
            5.6.4.1 TECHNICAL OVERVIEW
            5.6.4.2 MARKET ANALYSIS
      5.6.5 OTHERS

6 GLOBAL BRAIN MONITORING DEVICES MARKET, BY END-USER
  6.1 INTRODUCTION
      6.1.1 HOSPITALS ACCOUNTED FOR THE LARGEST SHARE OF THE BRAIN MONITORING DEVICES MARKET GLOBALLY
  6.2 ELECTROENCEPHALOGRAPH
      6.2.1 INCREASING NUMBER OF NEURO INTENSIVE CARE UNITS AND SLEEP CENTERS TO TRIGGER THE DEMAND FOR HOSPITAL-BASED EEG DEVICES
  6.3 TRANSCRANIAL DOPPLER
      6.3.1 HOSPITAL-BASED TCD DEVICES, CONSIDERED TO BE ‘STANDARD OF CARE’, FORMS THE LARGEST END-USER SEGMENT
  6.4 MAGNETOENCEPHALOGRAPH
      6.4.1 MEG DEVICES ARE LARGELY USED IN HOSPITALS AND RESEARCH INSTITUTES
  6.5 INTRACRANIAL PRESSURE MONITOR
      6.5.1 RISING NUMBER OF TRAUMA CENTERS EXPECTED TO BOOST THE DEMAND OF HOSPITAL-BASED ICP DEVICES
  6.6 CEREBRAL OXIMETER
      6.6.1 GROWTH IN THE FIELD OF CARDIAC CARE IS LIKELY TO PUSH THE DEMAND FOR HOSPITAL-BASED CEREBRAL OXIMETERS

7 GEOGRAPHIC ANALYSIS
  7.1 INTRODUCTION
      7.1.1 NORTH AMERICA AND EUROPE, DOMINATED THE BRAIN MONITORING DEVICES MARKET
      7.1.2 ASIAN REGION IS POISED TO REGISTER THE HIGHEST CAGR IN THE COMING FIVE YEARS
  7.2 NORTH AMERICA
      7.2.1 INTRODUCTION OF TECHNOLOGICALLY ADVANCED AND DIGITALIZED DEVICES TO REVIVE THE MARKET
      7.2.2 LARGE EPILEPSY PATIENT POOL AND INCREASE IN AGING POPULATION IS LIKELY TO FUEL THE DEMAND OF BRAIN MONITORING DEVICES
      7.2.3 RISE IN THE NUMBER OF NEUROCRITICAL CARE UNITS IS SLATED TO DRIVE THE MARKET
      7.2.4 REIMBURSEMENT SCENARIO, LIMITING THE GROWTH
  7.3 EUROPE
      7.3.1 LARGE NUMBER OF NEUROLOGICAL DISORDER PATIENTS IS LIKELY TO BOOST THE MARKET GROWTH
      7.3.2 INCREASED EMPHASIS ON LONG TERM MONITORING OF EPILEPSY BY HOSPITALS IS EXPECTED TO IMPEL THE MARKET GROWTH
      7.3.3 FINANCIALLY CHALLENGING CONDITIONS TO HINDER THE MARKET GROWTH
  7.4 ASIA
      7.4.1 ASIA SHOWCASES THE HIGHEST CAGR (2012 – 2017)
      7.4.2 ASIAN MARKET TO BE PROPELLED BY INFLUX OF DEVICE MANUFACTURERS
      7.4.3 INDIA AND CHINA OFFER HUGE MARKET POTENTIAL IN ASIAN REGION
      7.4.4 RISING PREVALENCE OF EPILEPSY AND SLEEP DISORDERS IS LIKELY TO FUEL THE ASIAN MARKET GROWTH
      7.4.5 HIGH COSTS OF DEVICES CURBING THE MARKET GROWTH
  7.5 REST OF THE WORLD (ROW)
      7.5.1 LATIN AMERICA, AUSTRALIA AND AFRICAN COUNTRIES ARE PROMISING GEOGRAPHIES

8 COMPETITIVE LANDSCAPE
  8.1 INTRODUCTION
  8.2 MERGERS & ACQUISITIONS
  8.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, CONTRACTS AND JOINT VENTURES
  8.4 NEW PRODUCT LAUNCH
  8.5 EXPANSION
  8.6 APPROVAL

9 COMPANY PROFILES(OVERVIEW, FINANCIAL, PRODUCTS & SERVICES, STRATEGY, AND DEVELOPMENTS)*
  9.1 ADVANCED BRAIN MONITORING, INC.
  9.2 ASTRO-MED, INC.
  9.3 ATYS MEDICAL
  9.4 CADWELL LABORATORIES, INC.
  9.5 CAS MEDICAL SYSTEMS, INC.
  9.6 COMPUMEDICS LIMITED
  9.7 CONTEC MEDICAL SYSTEMS CO. LTD.
  9.8 CORTECH SOLUTIONS, INC.
  9.9 COVIDIEN, PLC
  9.10 DEPUY SYNTHES COMPANIES
  9.11 ELCAT GMBH
  9.12 ELEKTA AB (PUBL)
  9.13 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  9.14 MEG INTERNATIONAL SERVICES LIMITED
  9.15 NATUS MEDICAL, INC.
  9.16 NIHON KOHDEN CORPORATION
  9.17 NONIN MEDICAL, INC.
  9.18 RIMED, LTD.
  9.19 YOKOGAWA ELECTRIC CORPORATION
*DETAILS ON OVERVIEW, FINANCIAL, PRODUCTS & SERVICES, STRATEGY AND DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
 
 
 
LIST OF TABLES

TABLE 1 GLOBAL BRAIN MONITORING DEVICES MARKET,  BY PRODUCT, 2010 – 2017 ($MILLION)
TABLE 2 GLOBAL BRAIN MONITORING DEVICES MARKET VOLUME,  BY PRODUCT, 2010 – 2017 (THOUSAND UNITS)
TABLE 3 ELECTROENCEPHALOGRAPHY DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 4 ELECTROENCEPHALOGRAPHY DEVICES MARKET VOLUME,  BY GEOGRAPHY, 2010 – 2017 (THOUSAND UNITS)
TABLE 5 ELECTROENCEPHALOGRAPHY DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 6 TRANSCRANIAL DOPPLER DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 7 TRANSCRANIAL DOPPLER DEVICES MARKET VOLUME,  BY GEOGRAPHY, 2010 – 2017 (THOUSAND UNITS)
TABLE 8 TRANSCRANIAL DOPPLER DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 9 MAGNETOENCEPHALOGRAPHY DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 10 MAGNETOENCEPHALOGRAPHY DEVICES MARKET VOLUME,  BY GEOGRAPHY, 2010 – 2017 (THOUSAND UNITS)
TABLE 11 MAGNETOENCEPHALOGRAPHY DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 12 INTRACRANIAL PRESSURE MONITOR DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 13 INTRACRANIAL PRESSURE MONITOR DEVICES MARKET VOLUME,  BY GEOGRAPHY, 2010 – 2017 (THOUSAND UNITS)
TABLE 14 INTRACRANIAL PRESSURE MONITOR DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 15 CEREBRAL OXIMETERSMARKET, BY GEOGRAPHY,  2010 – 2017 ($MILLION)
TABLE 16 CEREBRAL OXIMETERS MARKET VOLUME, BY GEOGRAPHY,  2010 – 2017 (THOUSAND UNITS)
TABLE 17 CEREBRAL OXIMETERSMARKET, BY END-USER,  2010 – 2017 ($MILLION)
TABLE 18 GLOBAL BRAIN MONITORING DEVICES ACCESSORIES MARKET,  BY PRODUCT, 2010 – 2017 ($MILLION)
TABLE 19 GLOBAL BRAIN MONITORING DEVICES ACCESSORIES MARKET VOLUME, BY PRODUCT, 2010 – 2017 (THOUSAND UNITS)
TABLE 20 ELECTRODES MARKET, BY GEOGRAPHY,  2010 – 2017 ($MILLION)
TABLE 21 ELECTRODES MARKET VOLUME, BY GEOGRAPHY,  2010 – 2017 (THOUSAND UNITS)
TABLE 22 SENSORS MARKET, BY GEOGRAPHY,  2010 – 2017 ($MILLION)
TABLE 23 SENSORS MARKET VOLUME, BY GEOGRAPHY,  2010 – 2017 (THOUSAND UNITS)
TABLE 24 PASTE AND GELS MARKET, BY GEOGRAPHY,  2010 – 2017 ($MILLION)
TABLE 25 PASTE AND GELS MARKET VOLUME, BY GEOGRAPHY,  2010 – 2017 (THOUSAND UNITS)
TABLE 26 CAPS MARKET, BY GEOGRAPHY,  2010 – 2017 ($MILLION)
TABLE 27 CAPS MARKET VOLUME, BY GEOGRAPHY,  2010 – 2017 (THOUSAND UNITS)
TABLE 28 CABLES MARKET, BY GEOGRAPHY,  2010 – 2017 ($MILLION)
TABLE 29 CABLES MARKET VOLUME, BY GEOGRAPHY,  2010 – 2017 (THOUSAND UNITS)
TABLE 30 BATTERIES MARKET, BY GEOGRAPHY,  2010 – 2017 ($MILLION)
TABLE 31 BATTERIES MARKET VOLUME, BY GEOGRAPHY,  2010 – 2017 (THOUSAND UNITS)
TABLE 32 OTHERS MARKET, BY GEOGRAPHY,  2010 – 2017 ($MILLION)
TABLE 33 GLOBAL BRAIN MONITORING DEVICES MARKET,  BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 34 GLOBAL EEG DEVICES MARKET, BY APPLICATION,  2010 – 2017 ($MILLION)
TABLE 35 EPILEPSY: EEG DEVICES MARKET, BY GEOGRAPHY,  2010 – 2017 ($MILLION)
TABLE 36 SLEEP DISORDERS: EEG DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 37 COMA & BRAIN DEATH: EEG DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 38 BRAIN TUMOR: EEG DEVICES MARKET, BY GEOGRAPHY,  2010 – 2017 ($MILLION)
TABLE 39 OTHERS: EEG DEVICES MARKET, BY GEOGRAPHY,  2010 – 2017 ($MILLION)
TABLE 40 GLOBAL TCD DEVICES MARKET, BY APPLICATION,  2010 – 2017 ($MILLION)
TABLE 41 INTRACRANIAL STENOSIS: TCD DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 42 SUBARACHNOID HEMORRHAGE: TCD DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 43 EMBOLI DETECTION: TCD DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 44 SICKLE CELL DISEASE: TCD DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 45 OTHERS: TCD DEVICES MARKET, BY GEOGRAPHY,  2010 – 2017 ($MILLION)
TABLE 46 GLOBAL MEG DEVICES MARKET, BY APPLICATION,  2010 – 2017 ($MILLION)
TABLE 47 BRAIN RESEARCH STUDIES: MEG DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 48 AUTISTIC DISORDERS: MEG DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 49 OTHERS: MEG DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 50 GLOBAL ICP DEVICES MARKET, BY APPLICATION,  2010 – 2017 ($MILLION)
TABLE 51 TRAUMATIC BRAIN INJURY: ICP DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 52 INTRACEREBRAL HEMORRHAGE: ICP DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 53 MENINGITIS: ICP DEVICES MARKET, BY GEOGRAPHY,  2010 – 2017 ($MILLION)
TABLE 54 OTHERS: ICP DEVICES MARKET, BY GEOGRAPHY,  2010 – 2017 ($MILLION)
TABLE 55 GLOBAL CEREBRAL OXIMETER DEVICES MARKET,  BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 56 CARDIAC/VASCULAR SURGERY: CEREBRAL OXIMETER DEVICES MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 57 SHOULDER SURGERY: CEREBRAL OXIMETER DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 58 SINGLE LUNG VENTILATION: CEREBRAL OXIMETER DEVICES MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 59 OTHERS: CEREBRAL OXIMETER DEVICES MARKET,  BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 60 GLOBAL ELECTROENCEPHALOGRAPHY DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 61 NORTH AMERICA: ELECTROENCEPHALOGRAPHY DEVICES MARKET, BY END-USER, 2010 – 2017 ($MILLION)
TABLE 62 EUROPE: ELECTROENCEPHALOGRAPHY DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 63 ASIA: ELECTROENCEPHALOGRAPHY DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 64 ROW: ELECTROENCEPHALOGRAPHY DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 65 GLOBAL TRANSCRANIAL DOPPLER DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 66 NORTH AMERICA: TRANSCRANIAL DOPPLER DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 67 EUROPE: TRANSCRANIAL DOPPLER DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 68 ASIA: TRANSCRANIAL DOPPLER DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 69 ROW: TRANSCRANIAL DOPPLER DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 70 GLOBAL MAGNETOENCEPHALOGRAPH DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 71 NORTH AMERICA: MAGNETOENCEPHALOGRAPH DEVICES MARKET, BY END-USER, 2010 – 2017 ($MILLION)
TABLE 72 EUROPE: MAGNETOENCEPHALOGRAPH DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 73 ASIA: MAGNETOENCEPHALOGRAPH DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 74 ROW: MAGNETOENCEPHALOGRAPH DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 75 GLOBAL INTRACRANIAL PRESSURE MONITOR DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 76 NORTH AMERICA: INTRACRANIAL PRESSURE MONITOR DEVICES MARKET, BY END-USER, 2010 – 2017 ($MILLION)
TABLE 77 EUROPE: INTRACRANIAL PRESSURE MONITOR DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 78 ASIA: INTRACRANIAL PRESSURE MONITOR DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 79 ROW: INTRACRANIAL PRESSURE MONITOR DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 80 GLOBAL CEREBRAL OXIMETER DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 81 NORTH AMERICA: CEREBRAL OXIMETER DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 82 EUROPE: CEREBRAL OXIMETER DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 83 ASIA: CEREBRAL OXIMETER DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 84 ROW: CEREBRAL OXIMETER DEVICES MARKET,  BY END-USER, 2010 – 2017 ($MILLION)
TABLE 85 BRAIN MONITORING DEVICES MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 86 BRAIN MONITORING DEVICES MARKET VOLUME,  BY GEOGRAPHY, 2010 – 2017 (THOUSAND UNITS)
TABLE 87 NORTH AMERICA: BRAIN MONITORING DEVICES MARKET,  BY PRODUCT, 2010 – 2017 ($MILLION)
TABLE 88 NORTH AMERICA: BRAIN MONITORING DEVICES MARKET VOLUME, BY PRODUCT, 2010 – 2017 (THOUSAND UNITS)
TABLE 89 EUROPE: BRAIN MONITORING DEVICES MARKET, BY PRODUCT, 2010 – 2017 ($MILLION)
TABLE 90 EUROPE: BRAIN MONITORING DEVICES MARKET VOLUME,  BY PRODUCT, 2010 – 2017 (THOUSAND UNITS)
TABLE 91 ASIA: BRAIN MONITORING DEVICES MARKET, BY PRODUCT, 2010 – 2017 ($MILLION)
TABLE 92 ASIA: BRAIN MONITORING DEVICES MARKET VOLUME, BY PRODUCT, 2010 – 2017 (THOUSAND UNITS)
TABLE 93 ROW: BRAIN MONITORING DEVICES MARKET, BY PRODUCT, 2010 – 2017 ($MILLION)
TABLE 94 ROW: BRAIN MONITORING DEVICES MARKET VOLUME, BY PRODUCT, 2010 – 2017 (THOUSAND UNITS)
TABLE 95 MERGERS & ACQUISITIONS, 2010 – 2013
TABLE 96 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, CONTRACTS AND JOINT VENTURES, 2010 – 2012
TABLE 97 NEW PRODUCT LAUNCH, 2010 – 2012
TABLE 98 EXPANSION, 2010 – 2012
TABLE 99 APPROVAL, 2010 – 2012
TABLE 100 ASTRO-MED, INC.: TOTAL REVENUE AND R&D EXPENDITURE,  2010 – 2012 ($MILLION)
TABLE 101 ASTRO-MED, INC.: TOTAL REVENUE, BY SEGMENT,  2010 – 2012 ($MILLION)
TABLE 102 ASTRO-MED, INC.: TOTAL REVENUE, BY GEOGRAPHY,  2010 – 2012 ($MILLION)
TABLE 103 CAS MEDICAL SYSTEMS, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011($MILLION)
TABLE 104 CAS MEDICAL SYSTEMS, INC.: TOTAL REVENUE,  BY SEGMENT, 2009 – 2011 ($MILLION)
TABLE 105 CAS MEDICAL SYSTEMS, INC.: TOTAL REVENUE,  BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 106 COMPUMEDICS LIMITED: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 107 COMPUMEDICS LIMITED: TOTAL REVENUE,  BY SEGMENT, 2010 – 2012($MILLION)
TABLE 108 COMPUMEDICS LIMITED: TOTAL REVENUE,  BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 109 COVIDIEN, PLC: TOTAL REVENUE AND R&D EXPENDITURE,  2010 – 2012($MILLION)
TABLE 110 COVIDIEN, PLC: TOTAL REVENUE,  BY SEGMENT, 2010 – 2012($MILLION)
TABLE 111 COVIDIEN, PLC: TOTAL REVENUE OF MEDICAL DEVICES,  BY SEGMENT, 2010 – 2012 ($MILLION)
TABLE 112 COVIDIEN, PLC: TOTAL REVENUE, BY GEOGRAPHY,  2010 – 2012($MILLION)
TABLE 113 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011($MILLION)
TABLE 114 JOHNSON AND JOHNSON: TOTAL REVENUE,  BY SEGMENT 2009-2011($MILLION)
TABLE 115 JOHNSON & JOHNSON: MEDICAL DEVICES AND DIAGNOSTICS REVENUE, BY DIVISION, 2009 - 2011($MILLION)
TABLE 116 JOHNSON & JOHNSON: TOTAL REVENUE,  BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 117 ELEKTA AB: TOTAL REVENUE AND R&D EXPENDITURE,  2010 – 2012 ($MILLION)
TABLE 118 ELEKTA AB: TOTAL REVENUE, BY SEGMENT,  2010 – 2012 ($MILLION)
TABLE 119 ELEKTA AB: TOTAL REVENUE, BY GEOGRAPHY,  2010 – 2012 ($MILLION)
TABLE 120 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011($MILLION)
TABLE 121 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: TOTAL REVENUE, BY SEGMENT, 2009 – 2011($MILLION)
TABLE 122 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011($MILLION)
TABLE 123 NATUS MEDICAL, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011($MILLION)
TABLE 124 NATUS MEDICAL, INC.: TOTAL REVENUE, BY SEGMENT, 2009 – 2011 ($MILLION)
TABLE 125 NATUS MEDICAL, INC.: TOTAL REVENUE,  BY SEGMENT, 2009 – 2011 ($MILLION)
TABLE 126 NATUS MEDICAL, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011($MILLION)
TABLE 127 NIHON KOHDEN CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012($MILLION)
TABLE 128 NIHON KOHDEN CORPORATION: TOTAL REVENUE,  BY SEGMENT, 2010 – 2012($MILLION)
TABLE 129 NIHON KOHDEN CORPORATION: TOTAL REVENUE,  BY GEOGRAPHY, 2010 – 2012($MILLION)
TABLE 130 YOKOGAWA ELECTRIC CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 131 YOKOGAWA ELECTRIC CORPORATION: TOTAL REVENUE, BY SEGMENT, 2010 – 2012 ($MILLION)
TABLE 132 YOKOGAWA ELECTRIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012($MILLION)
 
 
LIST OF FIGURES
 
FIGURE 1 BRAIN MONITORING DEVICES MARKET, GEOGRAPHIC RANKING,2012
FIGURE 2 GLOBAL BRAIN MONITORING DEVICES MARKET, 2012& 2017 ($MILLION)
FIGURE 3 BRAIN MONITORING DEVICES MARKET, BY PRODUCT
FIGURE 4 BRAIN MONITORING DEVICES MARKET, BY APPLICATION
FIGURE 6 MARKET DYNAMICS
FIGURE 7 GLOBAL EEG DEVICES MARKET SHARE, BY KEY PLAYERS, 2012
FIGURE 8 GLOBAL TCD DEVICES MARKET SHARE, BY KEY PLAYERS, 2012
FIGURE 9 GLOBAL MEG DEVICES MARKET SHARE, BY KEY PLAYERS, 2012
FIGURE 10 BRAIN MONITORING DEVICES MARKET, BY ACCESSORIES
FIGURE 11 GLOBAL EEG DEVICES MARKET, BY APPLICATION
FIGURE 12 GLOBAL TCD DEVICES MARKET, BY APPLICATION
FIGURE 13 GLOBAL MEG DEVICES MARKET, BY APPLICATION
FIGURE 14 GLOBAL ICP DEVICES MARKET, BY APPLICATION
FIGURE 15 GLOBAL CEREBRAL OXIMETER DEVICES MARKET,  BY APPLICATION
FIGURE 16 GLOBAL BRAIN MONITORING DEVICES MARKET,  BY END-USER, 2012
FIGURE 17 KEY GROWTH STRATEGIES, 2010 – 2013

The global brain monitoring devices market is fragmented into different categories based on its product, application, and end-user. The product category includes electroencephalograph (EEG), Transcranial Doppler (TCD), magnetoencephalography (MEG), intracranial pressure monitor (ICP) and cerebral oximeter and accessories. This market is further segmented on the basis of applications of each product segment. The EEG devices application market comprises of epilepsy, sleep disorder, coma and brain death, brain tumor and others, while TCD devices application market includes intracranial stenosis, subarachnoid hemorrhage, emboli detection, sickle cell disease, and others. The MEG devices applications market includes brain research studies, autistic disorders and others, the ICP devices applications market comprises of traumatic brain injury, intracerebral hemorrhage, meningitis and others, while cerebral oximeter devices application market includes cardiac/vascular surgery, shoulder surgery, single lung ventilation and others. The global brain monitoring devices market was valued at $1.08 billion in 2012, and is poised to grow at a CAGR of 8.6% to reach $1.63 billion by 2017.

The brain monitoring devices market is witnessing various technological advancements leading to high functionality, lower costs, ease of operation, and miniaturization of devices fuelling the growth of this market. In the past, brain monitoring was not given much importance during routine checkups, preoperative and post-operative periods, and in critical care settings. However, this scenario is changing, with brain monitoring now being widely practiced to assess the depths of anesthesia and sedation. It is being used in a variety of clinical settings, which include operating rooms, intensive care units, and ambulatory units, which, in turn, will fuel demand for brain monitoring devices such as EEG, ICP, and cerebral oximeters in the coming years.

North America dominated the global brain monitoring devices market, followed by Europe, Asia, and Rest of the World (RoW) in 2012. North America will continue to lead in the years to come, owing to technological advancements and introduction of advanced digitalized devices such as wireless and mobile devices. European countries are expected to grow steadily, while the Asian region's contribution to the global brain monitoring devices market is expected to pick pace in the next few years due to increasing awareness of neurological disorders, and development in Asian healthcare infrastructure, which has resulted in an influx of well-established players to the region.

The prominent players operating in this market include Covidien, PLC (Ireland), Compumedics, Ltd.(Australia), Natus Medical, Inc. (U.S.), Nihon Kohden Corporation (Japan), Integra Life Sciences Corporation (U.S.), CAS Medical Systems (U.S.), and Advanced Brain Monitoring Inc. (U.S.), among others.

GLOBAL BRAIN MONITORING DEVICES MARKET REVENUE,2012 & 2017 ($MILLION)

Source: Annual Reports, SEC Filings, Expert Interviews, MnM Analysis